Skip to main content
Erschienen in: Diabetologia 3/2004

01.03.2004 | Article

Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice

verfasst von: A. Giulietti, C. Gysemans, K. Stoffels, E. van Etten, B. Decallonne, L. Overbergh, R. Bouillon, C. Mathieu

Erschienen in: Diabetologia | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

1,25-dihydroxyvitamin D3, the active form of vitamin D, prevents Type 1 diabetes in non-obese diabetic (NOD) mice. Epidemiological data show a threefold increase in human Type 1 diabetes when vitamin D deficiency was present in the first months of life. To evaluate whether a similar dietary deficiency affects diabetes incidence in NOD mice, we generated NOD mice with vitamin D deficiency in early life.

Methods

Breeding pairs of NOD mice, as well as their offspring (test mice), were kept in surroundings devoid of ultraviolet light and were fed a vitamin D-depleted diet for 100 days. Mice were followed for 250 days.

Results

At 250 days, 35% (12/35) male and 66% (22/33) female vitamin D-deficient mice were diabetic compared to 15% (6/40, p=0.05) and 45% (13/29, p<0.01) of the control mice. At 100 days no difference in insulitis was seen, but more vitamin D-deficient mice were glucose intolerant. Higher IL1 expression was detected in islets of vitamin D-deficient mice and their peritoneal macrophages had an aberrant cytokine profile (low IL1 and IL6, high IL15). Thymus and lymph nodes of vitamin D-deficient mice contained less CD4+CD62L+ cells.

Conclusion/interpretation

Vitamin D status increases the expression of Type 1 diabetes in NOD mice. Our data in NOD mice, as well as human epidemiological data, point to the importance of preventing vitamin D deficiency in early childhood. Controlling this dietary factor could be an easy and safe way to reduce the incidence of Type 1 diabetes in subjects who are genetically at risk.
Literatur
1.
Zurück zum Zitat Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M (2002) Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115:18–29CrossRefPubMed Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M (2002) Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115:18–29CrossRefPubMed
2.
Zurück zum Zitat Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of Type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055CrossRefPubMed Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of Type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055CrossRefPubMed
3.
Zurück zum Zitat Green A, Patterson CC (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 44 [Suppl 3]:B3–B8 Green A, Patterson CC (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 44 [Suppl 3]:B3–B8
4.
Zurück zum Zitat Ponsonby AL, McMichael A, Mei I van der (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181–182:71–78 Ponsonby AL, McMichael A, Mei I van der (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181–182:71–78
5.
Zurück zum Zitat Serrano-Rios M, Goday A, Martinez LT (1999) Migrant populations and the incidence of type 1 diabetes mellitus: an overview of the literature with a focus on the Spanish-heritage countries in Latin America. Diabetes Metab Res Rev 15:113–132CrossRefPubMed Serrano-Rios M, Goday A, Martinez LT (1999) Migrant populations and the incidence of type 1 diabetes mellitus: an overview of the literature with a focus on the Spanish-heritage countries in Latin America. Diabetes Metab Res Rev 15:113–132CrossRefPubMed
6.
Zurück zum Zitat Feltbower RG, Bodansky HJ, McKinney PA, Houghton J, Stephenson CR, Haigh D (2002) Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet Med 19:162–166CrossRefPubMed Feltbower RG, Bodansky HJ, McKinney PA, Houghton J, Stephenson CR, Haigh D (2002) Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet Med 19:162–166CrossRefPubMed
7.
Zurück zum Zitat Mathieu C, Van Etten E, Gysemans C et al. (2001) In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 16:2057–2065CrossRefPubMed Mathieu C, Van Etten E, Gysemans C et al. (2001) In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 16:2057–2065CrossRefPubMed
8.
Zurück zum Zitat Van Etten E, Branisteanu DD, Overbergh L, Bouillon R, Verstuyf A, Mathieu C (2003) Combination of a 1,25-dihydroxyvitamin D(3) analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 32:397–404CrossRef Van Etten E, Branisteanu DD, Overbergh L, Bouillon R, Verstuyf A, Mathieu C (2003) Combination of a 1,25-dihydroxyvitamin D(3) analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 32:397–404CrossRef
9.
Zurück zum Zitat Tsuji M, Fujii K, Nakano T, Nishii Y (1994) 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 337:248–250CrossRefPubMed Tsuji M, Fujii K, Nakano T, Nishii Y (1994) 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 337:248–250CrossRefPubMed
10.
Zurück zum Zitat Larsson P, Mattsson L, Klareskog L, Johnsson C (1998) A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114:277–283CrossRefPubMedPubMedCentral Larsson P, Mattsson L, Klareskog L, Johnsson C (1998) A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114:277–283CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552–558CrossRefPubMed Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552–558CrossRefPubMed
12.
Zurück zum Zitat Casteels KM, Mathieu C, Waer M et al. (1998) Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 139:95–102PubMed Casteels KM, Mathieu C, Waer M et al. (1998) Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 139:95–102PubMed
13.
Zurück zum Zitat Mathieu C, Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174–179CrossRefPubMed Mathieu C, Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174–179CrossRefPubMed
14.
Zurück zum Zitat The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef
15.
Zurück zum Zitat Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 43:1093–1098CrossRefPubMed Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 43:1093–1098CrossRefPubMed
16.
Zurück zum Zitat Harris S (2002) Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutr Rev 60:118–121CrossRefPubMed Harris S (2002) Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutr Rev 60:118–121CrossRefPubMed
17.
Zurück zum Zitat Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503CrossRefPubMed Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503CrossRefPubMed
18.
Zurück zum Zitat Verhaeghe J, Van Herck E, Van Bree R, Van Assche FA, Bouillon R (1989) Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 120:143–151CrossRefPubMed Verhaeghe J, Van Herck E, Van Bree R, Van Assche FA, Bouillon R (1989) Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 120:143–151CrossRefPubMed
19.
Zurück zum Zitat Gysemans C, Waer M, Laureys J et al. (2000) Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells. Clin Exp Immunol 121:557–565CrossRefPubMedPubMedCentral Gysemans C, Waer M, Laureys J et al. (2000) Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells. Clin Exp Immunol 121:557–565CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491–1495CrossRefPubMed Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491–1495CrossRefPubMed
21.
Zurück zum Zitat Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386–401CrossRefPubMed Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386–401CrossRefPubMed
22.
Zurück zum Zitat Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312CrossRefPubMed Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312CrossRefPubMed
23.
Zurück zum Zitat Chesney RW (2002) Rickets: the third wave. Clin Pediatr (Phila) 41:137–139 Chesney RW (2002) Rickets: the third wave. Clin Pediatr (Phila) 41:137–139
24.
Zurück zum Zitat Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361CrossRefPubMed Gale EA (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361CrossRefPubMed
25.
Zurück zum Zitat Bar-Shavit Z, Noff D, Edelstein S, Meyer M, Shibolet S, Goldman R (1981) 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int 33:673–676CrossRefPubMed Bar-Shavit Z, Noff D, Edelstein S, Meyer M, Shibolet S, Goldman R (1981) 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int 33:673–676CrossRefPubMed
26.
Zurück zum Zitat Stroder J, Kasal P (1970) Evaluation of phagocytosis in rickets. Acta Paediatr Scand 59:288–292CrossRefPubMed Stroder J, Kasal P (1970) Evaluation of phagocytosis in rickets. Acta Paediatr Scand 59:288–292CrossRefPubMed
27.
Zurück zum Zitat Wientroub S, Winter CC, Wahl SM, Wahl LM (1989) Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif Tissue Int 44:125–130CrossRefPubMed Wientroub S, Winter CC, Wahl SM, Wahl LM (1989) Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif Tissue Int 44:125–130CrossRefPubMed
28.
Zurück zum Zitat Kankova M, Luini W, Pedrazzoni M et al. (1991) Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73:466–471PubMedPubMedCentral Kankova M, Luini W, Pedrazzoni M et al. (1991) Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73:466–471PubMedPubMedCentral
29.
Zurück zum Zitat Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice. Diabetes 43:667–675CrossRefPubMed Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice. Diabetes 43:667–675CrossRefPubMed
30.
Zurück zum Zitat Rosmalen JG, Martin T, Dobbs C et al. (2000) Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. Lab Invest 80:23–30CrossRefPubMed Rosmalen JG, Martin T, Dobbs C et al. (2000) Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. Lab Invest 80:23–30CrossRefPubMed
31.
Zurück zum Zitat Serreze DV, Gaskins HR, Leiter EH (1993) Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534–2543PubMed Serreze DV, Gaskins HR, Leiter EH (1993) Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534–2543PubMed
32.
Zurück zum Zitat Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI (2000) Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49:1106–1115CrossRefPubMed Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI (2000) Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49:1106–1115CrossRefPubMed
33.
Zurück zum Zitat Waldmann TA (2002) The IL-2/IL-15 receptor systems: targets for immunotherapy. J Clin Immunol 22:51–56CrossRefPubMed Waldmann TA (2002) The IL-2/IL-15 receptor systems: targets for immunotherapy. J Clin Immunol 22:51–56CrossRefPubMed
34.
Zurück zum Zitat O’Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT (2002) Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51:2481–2488CrossRefPubMed O’Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT (2002) Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51:2481–2488CrossRefPubMed
35.
Zurück zum Zitat Bradley LM, Asensio VC, Schioetz LK et al. (1999) Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511–2520PubMed Bradley LM, Asensio VC, Schioetz LK et al. (1999) Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511–2520PubMed
36.
Zurück zum Zitat Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325–332CrossRefPubMed Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325–332CrossRefPubMed
37.
Zurück zum Zitat Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre- diabetic NOD mice. Diabetologia 46:255–266CrossRefPubMed Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre- diabetic NOD mice. Diabetologia 46:255–266CrossRefPubMed
38.
Zurück zum Zitat Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L (1998) Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate “active tolerance” in the nonobese diabetic mouse. J Immunol 161:2620–2628PubMed Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L (1998) Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate “active tolerance” in the nonobese diabetic mouse. J Immunol 161:2620–2628PubMed
39.
Zurück zum Zitat Weets I, Van Autreve J, Van der Auwera BJ et al. (2001) Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 44:40–47CrossRefPubMed Weets I, Van Autreve J, Van der Auwera BJ et al. (2001) Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 44:40–47CrossRefPubMed
40.
Zurück zum Zitat Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655–656CrossRefPubMed Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655–656CrossRefPubMed
41.
Zurück zum Zitat Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK (2000) Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23:1755–1760CrossRefPubMed Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK (2000) Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23:1755–1760CrossRefPubMed
42.
Zurück zum Zitat Gedik O, Akalin S (1986) Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142–145CrossRefPubMed Gedik O, Akalin S (1986) Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142–145CrossRefPubMed
43.
Zurück zum Zitat Kadowaki S, Norman AW (1984) Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73:759–766CrossRefPubMedPubMedCentral Kadowaki S, Norman AW (1984) Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73:759–766CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Nyomba BL, Bouillon R, De Moor P (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115:191–197CrossRefPubMed Nyomba BL, Bouillon R, De Moor P (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115:191–197CrossRefPubMed
45.
Zurück zum Zitat Baynes KC, Boucher BJ, Feskens EJ, Kromhout D (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40:344–347CrossRefPubMed Baynes KC, Boucher BJ, Feskens EJ, Kromhout D (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40:344–347CrossRefPubMed
46.
Zurück zum Zitat Boucher BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr 79:315–327CrossRefPubMed Boucher BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr 79:315–327CrossRefPubMed
47.
Zurück zum Zitat Mathieu C, Van Etten E, Gysemans C, Decallonne B, Bouillon R (2002) Seasonality of birth in patients with type 1 diabetes. Lancet 359:1248CrossRefPubMed Mathieu C, Van Etten E, Gysemans C, Decallonne B, Bouillon R (2002) Seasonality of birth in patients with type 1 diabetes. Lancet 359:1248CrossRefPubMed
48.
Zurück zum Zitat Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R (1995) Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136:866–872PubMed Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R (1995) Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136:866–872PubMed
Metadaten
Titel
Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice
verfasst von
A. Giulietti
C. Gysemans
K. Stoffels
E. van Etten
B. Decallonne
L. Overbergh
R. Bouillon
C. Mathieu
Publikationsdatum
01.03.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1329-3

Weitere Artikel der Ausgabe 3/2004

Diabetologia 3/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.